Physician profile
Joanna Y Quinn
NPI 1205190675
$899.53
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $265 · 2021: $205 · 2022: $73.64.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $252.28 | 2019-2020 | |
| Abbvie INC. | $159.88 | 2021-2022 | |
| Avion Pharmaceuticals | $135.80 | 2019-2020 | |
| Therapeuticsmd, INC. | $56.53 | 2019-2021 | |
| Coopersurgical, INC. | $44.89 | 2021 | |
| Allergan, INC. | $39.70 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $38.08 | 2019-2020 | |
| Exeltis, USA INC. | $37.64 | 2019-2020 | |
| Ethicon US, LLC | $32.77 | 2019-2020 | |
| Myovant Sciences INC. | $17.61 | 2022 | |
| Mylan Pharmaceuticals INC. | $17.54 | 2022 | |
| Vertical Pharmaceuticals, LLC | $14.66 | 2019 | |
| Evofem Biosciences, INC. | $13.99 | 2021 | |
| Lupin INC. | $13.66 | 2019 | |
| Specialty Surgical Instrumentation | $12.67 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $11.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.